Yu X, Luo Z, Tang J, Yu P
Shandong Medical University, Jinan, 250012.
Se Pu. 1997 Nov;15(6):546-7.
This paper describes a reliable method for the pharmacokinetic study of Sulpride in human plasma by reversed-phase high performance liquid chromatography. To compensate the loss of Sulpride during the extraction procedure we used an internal standard very similar in chemical structure and UV absorbance to those of Sulpride. The mobile phase was methanol-water-acetic acid (60:30:1) with a flow rate of 1.2 mL/min. A UV detector was used at 290 nm. The linear range was 5-100 mg/L and the detectable limit was 1.0 mg/L. The recovery and RSD were 97.95%-99.96% and 2.6%-5.1% respectively. The results showed that this method is a sensitive and accurate one which makes the pharmacokinetic study of Sulpride possible. If the concentration was too low to be detected by UV monitor, a fluorescence detector could be used with the excitation wavelength at 299 nm and emission at 342 nm. We analyzed the plasma samples from 30 day-treated psychotic patients and got the satisfactory results.
本文描述了一种通过反相高效液相色谱法对人血浆中舒必利进行药代动力学研究的可靠方法。为补偿提取过程中舒必利的损失,我们使用了一种化学结构和紫外吸收与舒必利非常相似的内标物。流动相为甲醇 - 水 - 乙酸(60:30:1),流速为1.2 mL/min。使用紫外检测器,检测波长为290 nm。线性范围为5 - 100 mg/L,检测限为1.0 mg/L。回收率和相对标准偏差分别为97.95% - 99.96%和2.6% - 5.1%。结果表明该方法灵敏且准确,使得舒必利的药代动力学研究成为可能。如果浓度过低无法通过紫外监测器检测到,可以使用荧光检测器,激发波长为299 nm,发射波长为342 nm。我们分析了30例接受治疗的精神病患者的血浆样本,得到了满意的结果。